Endo Readies New Opana ER Dosages for the Market

Drug Industry Daily
A A
Endo Pharmaceuticals plans to launch three new dosage strengths of opioid analgesic Opana ER April 1.

To View This Article:

Login

Subscribe To Drug Industry Daily